The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ASACARD 162.5 mg prolonged release hard capsules

162.5 milligram(s) Capsule

New Haven Pharma (UK) LimitedPA1966/001/001

Main Information

Trade NameASACARD 162.5 mg prolonged release hard capsules
Active SubstancesAcetylsalicylic acid
Strength162.5 milligram(s)
Dosage FormCapsule
Licence HolderNew Haven Pharma (UK) Limited
Licence NumberPA1966/001/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC06 acetylsalicylic acid


Licence Issued01/10/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back